Liu R, Paxton WA, Choe S.
et al. Homozygous defect in HIV-1 co-receptors accounts for resistance for
some multiply exposed individuals to HIV-1 infection. Cell.1996;86:367-377.
Samson M, Libert F, Doranz BJ.
et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant
alleles of the CCR-5 chemokine receptor gene. Nature.1996;382:722-725.
Dean M, Carrington M, Winkler C.
et al. Genetic restriction of HIV-1 infection and progression to AIDS by a
deletion allele of the CKR5 structural gene. Science.1996;273:1856-1862.
Huang Y, Paxton WA, Wolinsky SM.
et al. The role of a mutant CCR5 allele in HIV-1
transmission and disease progression. Nat Med.1996;2:1240-1243.
Michael NL, Chang C, Louie LG.
et al. The role of viral phenotype and CCR-5 gene
defects in HIV-1 transmission and disease progression. Nat Med.1997;3:338-340.
Zimmerman PA, Buckler-White A, Alkhatib G.
et al. Inherited resistance to HIV-1 conferred by an inactivating mutation
in CC chemokine receptor 5: studies in populations with contrasting clinical
phenotypes, defined racial background and quantified risk. Mol Med.1997;3:23-26.
Biti R, Ffrench R, Young J, Bennetts B, Stewart G, Liang T. HIV-1 infection in an individual homozygous for the CCR5 deletion allele. Nat Med.1997;3:252-253.
O'Brien TR, Winkler C, Dean M.
et al. HIV-1 infection in a man homozygous for CCR5 Δ32. Lancet.1997;349:1219.
Theodorou I, Meyer L, Magierowska M, Katlama C, Rouzioux C.and the Seroco Study Group. HIV-1 infection in an individual homozygous for CCR5Δ32: Seroco Study Group. Lancet.1997;349:1219-1220.
Balotta C, Bagnarelli P, Violin M.
et al. Homozygous Δ32 deletion of the CCR-5 chemokine receptor gene in an HIV-1 infected patient. AIDS.1997;11:F67-F71.
Meyer L, Magierowska M, Hubert JB.
et al. Early protective effect of CCR5 Δ32
heterozygosity on HIV-1 disease progression: relationship with viral load. AIDS.1997;11:F73-F78.
Husman de Roda AM, Koot M, Cornelissen M.
et al. Association between CCR5 genotype and the
clinical course of HIV-1 infection. Ann Intern Med.1997;127:882-890.
Smith MW, Dean M, Carrington M, Huttley GA, O'Brien SJ. CCR5-Δ32 gene deletion in HIV-1 infected
Mayaux MJ, Blanche S, Rouzioux C.
et al. Maternal factors associated with perinatal HIV-1 transmission: the
French Cohort Study: 7 years of follow-up observation. J Acquir Immune Defic Syndr Hum Retrovirol.1995;8:188-194.
Fang G, Burger H, Grimson R.
et al. Maternal plasma HIV-1 RNA level: a determinant and projected threshold
for mother-to-child transmission. Proc Natl Acad Sci U S A.1995;92:12100-12104.
Dickover RE, Garraty EM, Herman SA.
et al. Identification of levels of maternal HIV-1 RNA associated with risk
of perinatal transmission. JAMA.1996;275:599-605.
Mayaux MJ, Dussaix E, Isopet J.
et al. Maternal viral load during pregnancy and mother-to-child transmission
of human immunodeficiency virus type 1: the French Perinatal Cohort Studies. J Infect Dis.1997;175:172-175.
Landesman SH, Kalish LA, Burns DN.
et al. Obstetrical factors and the transmission of human immunodeficiency
virus type 1 from mother to child. N Engl J Med.1996;334:1617-1623.
Mandelbrot L, Mayaux MJ, Bongain F.
et al. Obstetric factors and mother-to-child transmission of human immunodefiency
virus type 1: the French perinatal cohorts: SEROGEST French Pediatric HIV
Infection Study Group. Am J Obstet Gynecol.1996;175:661-667.
Wolinsky SM, Wike CM, Korber BTM.
et al. Selective transmission of human immunodeficiency virus type 1 variants
from mothers to infants. Science.1992;255:1134-1137.
Scarlatti G, Leitner T, Halapi E.
et al. Comparison of variable sequence region 3 of HIV-1 from infected children
with the RNA and DNA sequences of the virus populations of their mothers. Proc Natl Acad Sci U S A.1993;90:1721-1725.
Centers for Disease Control. Revised classification for HIV-1 infection in children. MMWR Morb Mortal Wkly Rep.1994;43(RR-12):1-10.
Strachan T, Read AP. Human Molecular Genetics . Oxford, England: Bios Scientific Publishers Ltd; 1996.
Blanche S, Mayaux MJ, Rouzioux C.
et al. Relationship of the course of HIV infection in children to the severity
of the disease in their mothers at delivery. N Engl J Med.1994;330:308-312.
Mayaux MJ, Burgard M, Teglas JP.
et al. Neonatal characteristics in rapidly progressive perinatally acquired
HIV-1 disease. JAMA.1996;275:606-610.
Martinson JJ, Chapman NH, Rees DC, Yan-Tat Liu, Clegg JB. Global distribution of the CCR5 gene 32-base
pair deletion. Nat Genet.1997;16:100-103.
Kourtis AP, Ibegbu C, Nahmias AJ.
et al. Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med.1996;335:1431-1436.
Winchester R, Chen Y, Rose S, Selby J, Borkowsky W. Major histocompatibility complex HLA class II DR allele DR B11501 and those encoding HLA DR 13 are
preferentially associated with a diminution in maternally transmitted HIV-1
in different ethnic groups: determination by an automated sequence-based typing
method. Proc Natl Acad Sci U S A.1995;92:12374-12378.
Just JJ, Abrams E, Louie LG.
et al. Influence of host genotype on progression to acquired immunodeficiency
syndrome among children with human immunodeficiency virus type 1. J Pediatr.1995;127:544-549.
Hill AV. HIV and HLA: confusion or complexity. Nat Med.1996;2:395-396.
Moore JP. Co-receptors: implications for HIV pathogenesis and therapy. Science.1997;276:51-52.
Smith MW, Dean M, Carrington M.
et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science.1997;277:959-965.
Michael NL, Louie LG, Rohrbaugh AL.
et al. The role of CCR5 and CCR2 polymorphisms in HIV-1 transmission and disease progression. Nat Med.1997;3:1160-1162.
Simmons G, Clapham PR, Picard L.
et al. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes
by a novel CCR5 antagonist. Science.1997;276:276-279.